PrymaLab
PrymaLab Analytical · In-house laboratory
3705 Music Branch Rd, Ashland, KY 41102 · +1 (606) 465-9063 · prymalab.net
Certificate no.
PL-26-00034
Verification key
U9FXNFGF
Scan or enter both at
prymalab.net/testing/verify
Certificate of Analysis · Lot release
GDF-8 1 mg
Lot PL-2609-034 · Lyophilized powder · Label claim 1 mg/vial
Tested in-house by PrymaLabIn-house analytical result,
not an independent third-party test
Lot / batch number
PL-2609-034
Date of analysis
2026-09-18
Retest / expiry
2028-09-16
Units in lot / sampled
250 / 2
Storage
−20 °C, desiccated, dark; avoid freeze–thaw
Certificate type
Lot COA, 2 pages
Compound
GDF-8 (Myostatin)
Recombinant human myostatin, mature homodimer
Molecular formula
C1100H1646N294O316S24 (homodimer; reduced-chain calculation)
Theoretical mass (avg.)
24,814.0 Da (reduced-chain calculation; 24,796.3 Da with the nine disulfides formed)
Structure
Two identical 109-residue chains (UniProt O14793 residues 267–375): DFGLDCDEHSTESRCCRYPLTVDFEAFGWDWIIAPKRYKANYCSGECEFVFLQKYPHTHLVHQANPRGSAGPCCTPTKMSPINMLYFNGKEQIIYGKIPAMVVDRCGCS; disulfide-linked homodimer (TGF-β cystine knot).
Purity · RP-HPLC, area %
99.10%
Specification 99.0% • main peak at 7.06 min
Identity · Observed Mass
24,814.2 Da
Theoretical 24,814.0 Da • +0.2 Da (8 ppm)
Overall conclusion
PASS
Meets every specification for the tests performed
| Test | Method | Specification | Result | Conclusion |
| Appearance | Visual inspection | White to off-white lyophilized powder | White lyophilized powder | PASS |
| Identity (mass) | LC-MS, ESI positive | Theoretical ± 1.0 Da | 24,814.2 Da | PASS |
| Purity | RP-HPLC, UV 214 nm, area% | 99.0% | 99.10% | PASS |
| Largest impurity | RP-HPLC, area% | 1.0% | 0.37% at 6.24 min | PASS |
| Water content | Karl Fischer | 5.0% | 1.8% | PASS |
| Bacterial endotoxin | LAL, kinetic | ≤ 5.0 EU/mg | 0.21 EU/mg | PASS |
| Sterility / bioburden | USP <71>, membrane filtration | No growth after 14 days | No growth; conforms | PASS |
1HPLC chromatogram
Data file: GDF8_PL-2609-034_20260918_01 · Column C18, 150 × 4.6 mm · UV 214 nm
Baseline uncropped; main peak and impurities labeled with retention times. Peak table on page 2.
2HPLC method · GDF8_PL-2609-034_20260918_01
Instrument
Waters Alliance e2695, SN E2695B742
Data System
Empower 3, Build 3471
Detection Wavelength
214 nm
Column
C18, 150 × 4.6 mm, 3.5 µm
Column Part / Serial
186003326 / USHX18211
Mobile Phase A
0.1% TFA in water
Mobile Phase B
0.1% TFA in MeCN
Sample Diluent
Water, 0.1% TFA
Sample Concentration
0.5 mg/mL
Reference Standard
In-house GDF-8 reference, lot PL-RS-GD8-01, RT 7.04 min
3Gradient program
| Time (min) | % A | % B |
| 0.0 | 95 | 5 |
| 3.0 | 95 | 5 |
| 7.0 | 55 | 45 |
| 8.0 | 20 | 80 |
| 9.0 | 20 | 80 |
| 10.0 | 95 | 5 |
4Peak table
| Peak | RT (min) | Area | Area % |
| 1 | 5.62 | 10,750 | 0.25 |
| 2 | 6.24 | 15,910 | 0.37 |
| 3 | 7.06 | 4,261,300 | 99.10 |
| 4 | 7.68 | 12,040 | 0.28 |
| Total | | 4,300,000 | 100.00 |
Threshold 0.05% area · Blank subtracted: Y · Purity = main peak area ÷ total integrated area × 100, to two decimals; main peak shaded.
5Identity by mass spectrometry
Instrument
Waters Acquity SQD
Ionization / Mode
ESI, positive
Observed m/z (charge)
1241.7 (20+ [M+20H]) · 1128.9 (22+ [M+22H])
Deconvoluted Mass
24,814.2 Da
Theoretical Mass
24,814.0 Da
Difference
+0.2 Da (8 ppm)
Data File
GDF8_PL-2609-034_MS_20260918_01
Acceptance
Within ± 1.0 Da
6Additional tests
| Test | Performed by | Date | Report / file |
| Water content | PrymaLab | 2026-09-19 | RPT-KF-PL-2609-034 |
| Endotoxin | PrymaLab | 2026-09-20 | RPT-ET-PL-2609-034 |
| Sterility | PrymaLab | 2026-10-02 | RPT-ST-PL-2609-034 |
A test with no row here was not performed on this lot. Outside-laboratory reports, when used, are attached and named below.
7Review and approval
D. Reynolds
Analyst · performed the testing
Date: 2026-09-18
S. Calloway
Reviewer · checked against raw data
Date: 2026-10-02
M. Phelps
Lab Director · approved for release
Date: 2026-10-03